Erythrocyte agglutination assay
US4894347A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1988 |
| Grant date | Jan 16, 1990 |
| Priority date | — |
| Expiry date | Jan 13, 2008 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/80
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
In an erythrocyte agglutination assay, the agglutination reagent comprises at least one erythrocyte binding molecule coupled to at least one specific analyte binding molecule wherein the erythrocyte binding molecule does not cause agglutination when incubated with erythrocytes in the absence of analyte. Preferably, the erythrocytes are endogenous to the blood sample to be tested, that is, a whole blood sample is assayed. Mixtures of conjugates and conjugates of analyte analogues with erythrocyte binding molecules may also be used as agglutination reagents. The reagents and their use in direct or indirect assays is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.